Skip to Main Content

Author Details

Douglas B Sawyer
Center for Molecular Medicine, Maine Medical Center Research Institute
1985
195
66
PMIDPaper TitleJournal TitlePublished Year
35246910The number of circulating CD26 expressing cells is decreased in critical COVID-19 illness.Cytometry A2023
37364162Decreased circulating CD73 and adenosine deaminase are associated with disease severity in hospitalized patients with COVID-19.Int J Immunopathol Pharmacol2023
34043838Rural disparities in end-of-life care for patients with heart failure: Are they due to geography or socioeconomic disparity?J Rural Health2022
35844009Cardiovascular disease associated with methamphetamine use: a review.Heart Fail Rev2022
35609807Decreased expression of ErbB2 on left ventricular epicardial cells in patients with diabetes mellitus.Cell Signal2022
35691479Heart to Heart Discussions: Characterizing Goals of Care Conversations for Advanced Heart Failure Patients Initiating Palliative Inotropes.J Card Fail2022
35625411Neuregulin (NRG-1β) Is Pro-Myogenic and Anti-Cachectic in Respiratory Muscles of Post-Myocardial Infarcted Swine.Biology (Basel)2022
36281353Community consultation for Exception from Informed consent (EFIC) before and during the COVID-19 pandemic.Resusc Plus2022
35246202Ceftriaxone to PRevent pneumOnia and inflammaTion aftEr Cardiac arresT (PROTECT): study protocol for a randomized, placebo-controlled trial.Trials2022
33259856Protective role of ErbB3 signaling in myeloid cells during adaptation to cardiac pressure overload.J Mol Cell Cardiol2021
34789851DEspR<sup>high</sup> neutrophils are associated with critical illness in COVID-19.Sci Rep2021
33403831Modification of ventriculo-arterial coupling by spironolactone in nonischemic dilated cardiomyopathy.ESC Heart Fail2021
33422565Circulating growth factors and cardiac remodeling in the community: The Framingham Heart Study.Int J Cardiol2021
32251632High ErbB3 activating activity in human blood is not due to circulating neuregulin-1 beta.Life Sci2020
34396255Anthracycline-Induced Vascular Dysfunction: Is MitoQ the Answer?JACC CardioOncol2020
33094495Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).Eur J Heart Fail2020
33063822Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease.Clin Sci (Lond)2020
32862771What is Quality End-of-Life Care for Patients With Heart Failure? A Qualitative Study With Physicians.J Am Heart Assoc2020
321180403D Co-culture of hiPSC-Derived Cardiomyocytes With Cardiac Fibroblasts Improves Tissue-Like Features of Cardiac Spheroids.Front Mol Biosci2020
32199337Prolonged Cardiopulmonary Bypass is Associated With Endothelial Glycocalyx Degradation.J Surg Res2020
30273572Intensity of Glycemic Control Affects Long-Term Survival After Coronary Artery Bypass Graft Surgery.Ann Thorac Surg2019
32154009Systemic and cardiac susceptibility of immune compromised mice to doxorubicin.Cardiooncology2019
31237169Number of Circulating CD 73-Expressing Lymphocytes Correlates With Survival After Cardiac Arrest.J Am Heart Assoc2019
30922063Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.Circulation2019
31120822Anthracycline and Peripartum Cardiomyopathies.Circ Res2019
29291395ErbB2 promotes endothelial phenotype of human left ventricular epicardial highly proliferative cells (eHiPC).J Mol Cell Cardiol2018
29991489Anthracycline Cardiomyopathy: The Plot Gets Thinner.Circ Heart Fail2018
29871526Effects of endogenous serum neuregulin-1β on morbidity and mortality in patients with heart failure and left ventricular systolic dysfunction.Biomarkers2018
30631583Successful rebuilding after disaster, even in the heart, starts with infrastructure.J Thorac Dis2018
30286821Timing of Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy.Am J Med Sci2018
30364485Assessment of brain-derived neurotrophic factor and osteopontin in a healthy pediatric population.J Circ Biomark2018
28990334What's Next for Acute Heart Failure Research?Acad Emerg Med2018
29248417Altered ADAMTS5 Expression and Versican Proteolysis: A Possible Molecular Mechanism in Barlow's Disease.Ann Thorac Surg2018
27940336Myocardial T1 Measurement Predicts Beneficial LV Remodeling After Long-Term Heart Failure Therapy.J Card Fail2017
32264105Gradient release of cardiac morphogens by photo-responsive polymer micelles for gradient-mediated variation of embryoid body differentiation.J Mater Chem B2017
28390424GRMD cardiac and skeletal muscle metabolism gene profiles are distinct.BMC Med Genomics2017
28279426Cardio-Oncology-A Rapidly Evolving and Expanding Field of Medicine.Heart Fail Clin2017
28263756Neuregulin-1β induces proliferation, survival and paracrine signaling in normal human cardiac ventricular fibroblasts.J Mol Cell Cardiol2017
28235789ERBB signaling attenuates proinflammatory activation of nonclassical monocytes.Am J Physiol Heart Circ Physiol2017
29326589Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength Scores.Front Pharmacol2017
28780372Species-specific effects of neuregulin-1β (cimaglermin alfa) on glucose handling in animal models and humans with heart failure.Toxicol Appl Pharmacol2017
28870731Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.J Card Fail2017
27993643Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction.Eur J Pharmacol2017
26692570Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways.Cardiovasc Res2016
30167542A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart Failure.JACC Basic Transl Sci2016
26672735Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy.Pediatr Res2016
27789582Cardiac Dysfunction Due to Cancer Therapy: Finding New Directions.Circ Res2016
28042345Biomimetic microstructure morphology in electrospun fiber mats is critical for maintaining healthy cardiomyocyte phenotype.Cell Mol Bioeng2016
27809600Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosis.Amyloid2016
27238918Getting the SCOOP-Survey of Cardiovascular Outcomes From Oncology Patients During Survivorship.Am J Med Sci2016
  • 1 - 50 of 195

Recommended Authors

Center for Genetic Medicine, Northwestern University Feinberg School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 0
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 2003
Number of shared co-authors 0
Vanderbilt University
Career Start Year 2001
Number of shared co-authors 3
Gladstone Institutes San Francisco
Career Start Year 2001
Number of shared co-authors 2
University of California davis
Career Start Year 2001
Number of shared co-authors 1
Medical University of Graz
Career Start Year 2001
Number of shared co-authors 7
Massachusetts General Hospital.
Career Start Year 2000
Number of shared co-authors 6
University of Alabama at Birmingham, 1670 University Boulevard
Career Start Year 1999
Number of shared co-authors 1
Baker Heart and Diabetes Institute
Career Start Year 1998
Number of shared co-authors 1
University of Toronto, University Avenue
Career Start Year 1996
Number of shared co-authors 2
University of California los angeles
Career Start Year 1994
Number of shared co-authors 1
University of California los angeles
Career Start Year 1993
Number of shared co-authors 4
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 0
University of Washington
Career Start Year 1993
Number of shared co-authors 2
University of California at Los Angeles
Career Start Year 1992
Number of shared co-authors 1
Institute for Precision Cardiovascular Medicine
Career Start Year 1992
Number of shared co-authors 4
University of Connecticut Health
Career Start Year 1992
Number of shared co-authors 0
University Medical Centers
Career Start Year 1991
Number of shared co-authors 0
University of Alabama at Birmingham, 1670 University Boulevard
Career Start Year 1989
Number of shared co-authors 0
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 16
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Career Start Year 1986
Number of shared co-authors 8
University of Maryland
Career Start Year 1986
Number of shared co-authors 2
Odense University Hospital
Career Start Year 1985
Number of shared co-authors 0
Beth Israel Deaconess Medical Center.
Career Start Year 1984
Number of shared co-authors 6
Beth Israel Deaconess Medical Center.
Career Start Year 1983
Number of shared co-authors 0
Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University
Career Start Year 1979
Number of shared co-authors 7
University Hospital Wurzburg
Career Start Year 1974
Number of shared co-authors 11
National Academy of Medicine.
Career Start Year 1974
Number of shared co-authors 2
National and Kapodistrian University of Athens
Career Start Year 1973
Number of shared co-authors 14

Collaborators

Co-authored papers 15
Vanderbilt University Medical Center
Co-authored papers 13
Vanderbilt University School of Medicine
Co-authored papers 12
University of Cincinnati
Co-authored papers 12
Co-authored papers 11
Co-authored papers 8
Vanderbilt University School of Medicine
Co-authored papers 8
Medical College of Georgia, Augusta University
Co-authored papers 7
Wayne State University School of Medicine.
Co-authored papers 6
Vanderbilt University Medical Center
Co-authored papers 6
Indiana University School of Medicine
Co-authored papers 6
Cedars-Sinai Medical Center
Co-authored papers 6
Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW
Co-authored papers 5
Vanderbilt University Medical Center
Co-authored papers 5
and Blood Institute, National Institutes of Health
Co-authored papers 5
Duke University School of Medicine
Co-authored papers 5
Cardiology University of California San Francisco (UCSF)
Co-authored papers 5
Stanford University School of Medicine
Co-authored papers 5
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Co-authored papers 5
Co-authored papers 5
Duke University
Co-authored papers 5
Vanderbilt University Medical Center
Co-authored papers 5
New York University Comprehensive Epilepsy Center
Co-authored papers 4
Baylor College of Medicine
Co-authored papers 4
University of Cincinnati
Co-authored papers 4
University of Cincinnati
Co-authored papers 4
Co-authored papers 4
Vanderbilt University Medical Center
Co-authored papers 4
Sidney Kimmel Medical College, Thomas Jefferson University
Co-authored papers 4
Vanderbilt University
Co-authored papers 3